FTI
25
-5
GT
24
-5
PLD
19
-4
EOG
26
-3
AMGN
17
-4
PBI
35
-3
WFC
52
-2
CMCSA
34
-4
L
45
6
WU
20
-8
BXP
13
-5
UPS
7
-5
CMI
33
-4
LOW
34
-5
LMT
25
5
ZBH
44
-3
HOG
27
-7
IRM
21
-7
AN
25
-2
NWS
56
9
FTI
25
-5
GT
24
-5
PLD
19
-4
EOG
26
-3
AMGN
17
-4
PBI
35
-3
WFC
52
-2
CMCSA
34
-4
L
45
6
WU
20
-8
BXP
13
-5
UPS
7
-5
CMI
33
-4
LOW
34
-5
LMT
25
5
ZBH
44
-3
HOG
27
-7
IRM
21
-7
AN
25
-2
NWS
56
9
Financhill
Back

Evaxion Biotech AS 10K Form

Sell
16

EVAX
Evaxion Biotech AS

Last Price:
$1.34
Seasonality Move:
1.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $3.3M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 127.87

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-11.5M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -69.51%

Evaxion Biotech AS Earnings Forecast

Key Evaxion Biotech AS Financial Ratios

  • The Research & Development expenses have been 312.71% of Revenue.
  • The Net Earning history of EVAX is -316.00% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Evaxion Biotech AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.8
Quick Ratio: 2.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 5.44

EVAX Technical Analysis vs Fundamental Analysis

Sell
16
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy or a Sell?